Johnson & Johnson (JNJ) Posts Strong Q4 and Full-Year 2023 Results with Sales and EPS Growth
Operational Sales and Adjusted EPS See Notable Increases Amidst Strategic Focus
Joaquin Duato Johnson Johnsons Interventional Solutions Comprehensive Financial Regional Sales Innovative Medicine
Source: yahoo.com